| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Sep―21 |
The first five years of SARS-CoV-2: inpatient treatment updates and future directions |
Matthew W. McCarthy |
| 2 |
[GO] |
2024―Feb―23 |
Simnotrelvir as a potential treatment for COVID-19 |
Matthew W. McCarthy |
| 3 |
[GO] |
2024―Feb―16 |
Patterns of corticosteroid use among remdesivir and matched patients and associated clinical outcomes in hospitalized COVID-19 patients |
Ivan Papic, Petra Bistrovic, Tatjana Keres, Maja Ortner Hadziabdic, Marko Lucijanic |
| 4 |
[GO] |
2023―Okt―12 |
The impact of age, disease severity, and vaccination status on antibiotic use in hospitalized patients with COVID-19 |
Joseph E Blais, Peng Wu |
| 5 |
[GO] |
2023―Okt―12 |
Response to: “the impact of age, disease severity, and vaccination status on antibiotic use in hospitalized patients with COVID-19” |
Matteo Bassetti, Giorgia Brucci, Antonio Vena, Daniele Roberto Giacobbe |
| 6 |
[GO] |
2023―Sep―21 |
Paxlovid as a potential treatment for long COVID |
Matthew W. McCarthy |
| 7 |
[GO] |
2023―Jul―19 |
Use of antibiotics in hospitalized patients with COVID-19: evolving concepts in a highly dynamic antimicrobial stewardship scenario |
Matteo Bassetti, Giorgia Brucci, Antonio Vena, Daniele Roberto Giacobbe |
| 8 |
[GO] |
2023―Mai―17 |
Metformin as a potential treatment for COVID-19 |
Matthew W. MCCarthy |
| 9 |
[GO] |
2023―Mrz―18 |
VV116 as a potential treatment for COVID-19 |
Matthew W. McCarthy |
| 10 |
[GO] |
2023―Mrz―16 |
Montelukast as a potential treatment for COVID-19 |
Matthew W. McCarthy |
| 11 |
[GO] |
2022―Nov―09 |
Ensitrelvir as a potential treatment for COVID-19 |
Matthew W. McCarthy |
| 12 |
[GO] |
2022―Okt―22 |
Treatment of severe COVID-19: an evolving paradigm |
Matthew W McCarthy |
| 13 |
[GO] |
2022―Okt―01 |
An update on the considerations for patients with rheumatic disease being treated with rituximab during the COVID-19 pandemic and the potential drug treatment strategies |
Benjamin Bennett, Hasan Tahir, Sujata Ganguly, Arumugam Moorthy |
| 14 |
[GO] |
2022―Mrz―28 |
What impact can molnupiravir have on the treatment of SARS-CoV-2 infection? |
Fatima Kayali, Marco Shiu Tsun Leung, Wilson Wong, Kara Pittendrigh Morgan, Amer Harky |
| 15 |
[GO] |
2022―Feb―23 |
Guidance for the pharmacological management of COVID-19 in the emergency setting |
Mohamad-Hani Temsah, Muneera Al-Jelaify, Ziad A Memish |
| 16 |
[GO] |
2022―Feb―01 |
Current and emerging immunomodulators for treatment of SARS-CoV2 infection (COVID-19) |
Matthew W. McCarthy |
| 17 |
[GO] |
2021―Okt―14 |
Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients |
Fabio Angeli, Paolo Verdecchia, Gianpaolo Reboldi |
| 18 |
[GO] |
2021―Aug―31 |
Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease |
Maryam Khan, Guntaj Kaur Singh, Sakina Abrar, Roshan Ganeshan, Kara Morgan, Amer Harky |
| 19 |
[GO] |
2021―Mrz―16 |
Does hydroxychloroquine still have any role in the COVID-19 pandemic? |
William HK Schilling, Nicholas J White |
| 20 |
[GO] |
2021―Mrz―11 |
Considerations of the effects of commonly investigated drugs for COVID-19 in the cholesterol synthesis pathway |
Juan Luis Gomez Marti, Adam M. Brufsky |
| 21 |
[GO] |
2021―Feb―26 |
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH) |
María Del Mar Gutierrez, Isabel Mur, María Gracia Mateo, Francesc Vidal, Pere Domingo |
| 22 |
[GO] |
2021―Feb―17 |
What are the considerations for treating pediatric asthma during the COVID-19 pandemic? |
Amelia Licari, Gian Luigi Marseglia |
| 23 |
[GO] |
2020―Dez―21 |
The management of hematologic malignancies during the COVID-19 pandemic |
Iwona Hus, Aleksander Salomon-Perzyński, Krzysztof Tomasiewicz, Tadeusz Robak |
| 24 |
[GO] |
2020―Okt―15 |
Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients |
Syed Shahzad Hasan, Chia Siang Kow, Amie Bain, Sallianne Kavanagh, Hamid A. Merchant, Muhammad Abdul Hadi |
| 25 |
[GO] |
2020―Aug―05 |
The trade-off dilemma in pharmacotherapy of COVID-19: systematic review, meta-analysis, and implications |
Sohil Khan, Michael R Gionfriddo, Nicolas Cortes-Penfield, Girish Thunga, Muhammad Rashid |
| 26 |
[GO] |
2020―Jul―13 |
Pharmacotherapeutic considerations in solid organ transplant patients with COVID-19 |
Simin Dashti-Khavidaki, Keyhan Mohammadi, Hossein Khalili, Azin Abdollahi |
